Article Information
History
- March 18, 2023.
Article Versions
- Version 1 (January 24, 2023 - 09:49).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Alexander Calderon1,2,
- Tamara Mestvirishvili3,
- Francesco Boccalatte4,
- Kelly V. Ruggles3 and
- Gregory David1,2,5,*
- 1Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, NYU Langone Health, New York, NY 10016, USA
- 2Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY 10016, USA
- 3Department of Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY 10016, USA
- 4Department of Pathology, New York University Grossman School of Medicine, NYU Langone Health, New York, NY 10016, USA
- 5Department of Urology, New York University Grossman School of Medicine, NYU Langone Health, New York, NY 10016, USA
- ↵*Corresponding author: Gregory David, PhD; gregory.david{at}nyulangone.org
Posted March 18, 2023.
The Sin3B chromatin modifier restricts cell cycle progression to dictate hematopoietic stem cell differentiation
